Literature DB >> 8529483

Metformin and free fatty acid metabolism.

S Del Prato1, S Marchetto, A Pipitone, M Zanon, S Vigili de Kreutzenberg, A Tiengo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8529483     DOI: 10.1002/dmr.5610110506

Source DB:  PubMed          Journal:  Diabetes Metab Rev        ISSN: 0742-4221


× No keyword cloud information.
  7 in total

Review 1.  Modern pharmacotherapies for type 2 diabetes mellitus.

Authors:  S H Hsia
Journal:  J Natl Med Assoc       Date:  2001-09       Impact factor: 1.798

Review 2.  A risk-benefit assessment of metformin in type 2 diabetes mellitus.

Authors:  H C Howlett; C J Bailey
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

3.  Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity.

Authors:  S E Oleandri; M Maccario; R Rossetto; M Procopio; S Grottoli; E Avogadri; C Gauna; C Ganzaroli; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

Review 4.  Current therapeutic options in type 2 diabetes mellitus: a practical approach.

Authors:  Michael T Sheehan
Journal:  Clin Med Res       Date:  2003-07

5.  The desert gerbil Psammomys obesus as a model for metformin-sensitive nutritional type 2 diabetes to protect hepatocellular metabolic damage: Impact of mitochondrial redox state.

Authors:  Inès Gouaref; Dominique Detaille; Nicolas Wiernsperger; Naim Akhtar Khan; Xavier Leverve; Elhadj-Ahmed Koceir
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

6.  Effects of metformin on the regulation of free Fatty acids in insulin resistance: a double-blind, placebo-controlled study.

Authors:  Manuel Castro Cabezas; Jeroen P H van Wijk; Jan Willem F Elte; Boudewijn Klop
Journal:  J Nutr Metab       Date:  2012-10-11

7.  Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes.

Authors:  R Basu; A Basu; V Chandramouli; B Norby; B Dicke; P Shah; O Cohen; B R Landau; R A Rizza
Journal:  Diabetologia       Date:  2008-09-04       Impact factor: 10.460

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.